# Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

> **NCT01768689** · NA · COMPLETED · sponsor: **pia raanani** · enrollment: 58 (actual)

## Conditions studied

- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Medication Adherence

## Interventions

- **BEHAVIORAL:** Adherence-encouraging interventions - Group meeting
- **BEHAVIORAL:** Adherence-encouraging interventions - Individual meetings
- **BEHAVIORAL:** Adherence-encouraging interventions - Monthly phone calls

## Key facts

- **NCT ID:** NCT01768689
- **Lead sponsor:** pia raanani
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01768689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01768689, "Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01768689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*